Han. “CD109 Is a Potential Biomarker for Malignant Tumors”. American Journal of Translational Medicine, vol. 4, no. 3, Nov. 2020, pp. 111-2, https://ajtm.journals.publicknowledgeproject.org/index.php/ajtm/article/view/589.